Filip Mundt

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Percutaneous Coronary Intervention

Subarachnoid Hemorrhage

Quality Improvement

Top Venues

Cancer immunology research

Open research Europe

This page only lists publications with an associated author ORCID identifier.

Publications

Signe Koggersbøl Skadborg, Simone Maarup, Arianna Draghi, Annie Borch, Sille Hendriksen, Filip Mundt, Vilde Pedersen, Matthias Mann, Ib Jarle Christensen, Jane Skjøth-Rasmussen, Christina Westmose Yde, Bjarne Winther Kristensen, Hans Skovgaard Poulsen, Benedikte Hasselbalch, Inge Marie Svane, Ulrik N Lassen, Sine Reker Hadrup
Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways. Cancer immunology research 12 (9) (2024)
Signe Koggersbøl Skadborg, Simone Maarup, Arianna Draghi, Annie Borch, Sille Hendriksen, Filip Mundt, Vilde Pedersen, Matthias Mann, Ib Jarle Christensen, Jane Skjøth-Rasmussen, Christina Westmose Yde, Bjarne Winther Kristensen, Hans Skovgaard Poulsen, Benedikte Hasselbalch, Inge Marie Svane, Ulrik N Lassen, Sine Reker Hadrup
Nivolumab reaches brain lesions in patients with recurrent glioblastoma and induces T-cell activity and upregulation of checkpoint pathways. Cancer immunology research (2024)
Filip Mundt, Nicolai J Wewer Albrechtsen, Sebastian Porsdam Mann, Peter Treit, Medini Ghodgaonkar-Steger, Martina O'Flaherty, Reinout Raijmakers, Juan Antonio Vizcaino, Albert J R Heck, Matthias Mann
Foresight in clinical proteomics: current status, ethical considerations, and future perspectives. Open research Europe 3 (2023)